1 terminated. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Terminated 1 |
Follow Mandibulofacial Dysostosis: new trials by email Literature Review of Mandibulofacial Dysostosis trials Research Report on Mandibulofacial Dysostosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD Crisaborole ointment, 2%, Hydrocortisone butyrate cream, 0.1%, Pimecrolimus cream, 1% - Atopic Dermatitis | Phase 4 | Terminated | Pfizer | 237 | 2018-04-27 | 2022-01-10 |
Bone Diseases (1) · Bone Diseases, Developmental (1) · Coloboma (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Craniofacial Abnormalities (1) · Craniofacial Dysostosis (1) · Dermatitis (1) · Dysostoses (1) · Eye Diseases (1) · Eye Diseases, Hereditary (1) · Genetic Diseases, Inborn (1) · Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Immune System Diseases (1)
crisaborole (1) · pimecrolimus (1)
Pfizer (1)
Germany (1) · Italy (1) · Poland (1) · Sweden (1) · Switzerland (1) · United Kingdom (1) · United States (1)
2018 (1)